This is a firm fixed-price purchase order contract award to Quva Pharma, Inc., a for-profit pharmaceutical company, by the National Institutes of Health (NIH) Clinical Center. The $100,000.00 contract, which has a period of performance ending on February 18, 2026, is for the delivery of specialized sterile compounded pharmaceutical products to support the NIH Clinical Center's pain management initiatives and clinical research needs.
Quva Pharma is an experienced federal contractor, holding a single-award indefinite delivery contract (IDV) with the NIH Clinical Center valued at up to $250,000 for the procurement of non-patient-specific sterile compounded pharmaceutical products. This latest award does not have a set-aside designation. Quva Pharma's expertise includes providing patient-controlled analgesia systems, epidurals, and other sterile intravenous preparations to civilian federal healthcare agencies.
Generated 2/20/25, 9:05 AM